Literature DB >> 27573593

Coronary artery disease and Helicobacter pylori infection: Should we consider eradication therapy as cardiovascular prevention strategy?

Marco Zuin1, Gianluca Rigatelli2, Giuseppe Del Favero3, Claudio Picariello4, Tamara Meggiato3, Luca Conte4, Giuseppe Faggian5, Giovanni Zuliani6, Loris Roncon7.   

Abstract

Entities:  

Keywords:  Cardiovascular prevention; Coronary artery disease; Helicobacter pylori

Mesh：

Substances：

Year:  2016        PMID： 27573593     DOI： 10.1016/j.ijcard.2016.08.320

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  4 in total

1.  Helicobacter pylori infection and severity of coronary atherosclerosis in patients with chronic coronary artery disease.

Authors:  Anita Jukic; Dorotea Bozic; Dusko Kardum; Tina Becic; Bruno Luksic; Mislav Vrsalovic; Marko Ljubkovic; Damir Fabijanic
Journal:  Ther Clin Risk Manag       Date:  2017-07-27       Impact factor: 2.423

2.  Current Helicobacter pylori infection is significantly associated with subclinical coronary atherosclerosis in healthy subjects: A cross-sectional study.

Authors:  Minyoung Lee; Haeri Baek; Jong Suk Park; Sohee Kim; Chanhee Kyung; Su Jung Baik; Byoung Kwon Lee; Jie-Hyun Kim; Chul Woo Ahn; Kyung Rae Kim; Shinae Kang
Journal:  PLoS One       Date:  2018-03-02       Impact factor: 3.240

Review 3.  Helicobacter pylori and unignorable extragastric diseases: Mechanism and implications.

Authors:  Junjian He; Yunyi Liu; Qin Ouyang; Rongxing Li; Jie Li; Weiyan Chen; Weichao Hu; Lijiao He; Qiyu Bao; Ping Li; Changjiang Hu
Journal:  Front Microbiol       Date:  2022-08-04       Impact factor: 6.064

4.  Interaction between MyD88, TIRAP and IL1RL1 against Helicobacter pylori infection.

Authors:  Andrea Fulgione; Marina Papaianni; Paola Cuomo; Debora Paris; Marco Romano; Concetta Tuccillo; Letizia Palomba; Chiara Medaglia; Massimiliano De Seta; Nicolino Esposito; Andrea Motta; Antonio Iannelli; Domenico Iannelli; Rosanna Capparelli
Journal:  Sci Rep       Date:  2020-09-28       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.